article thumbnail

Orthopedics Market: Rising Burden of Orthopedic Diseases in Developed Countries to Drive the Market

The Pharma Data

Orthopedics Market: Overview. Strides in the orthopedics market have been primarily driven by changing demographic profile of patient populations and advances made in orthopedic surgeries. Concomitant research in biomaterials, biomechanics, electrophysiology, and molecular biology has expanded the horizon of the orthopedics market.

article thumbnail

De-risking drug discovery with predictive AI

Broad Institute

As of now, papers describing three of these machine learning tools have been published, in the Journal of Chemical Information and Modeling , Molecular Biology of the Cell , and Chemical Research in Toxicology. Molecular Biology of the Cell. A fourth is in the works. DOI: 10.1021/acs.chemrestox.4c00015. Seal S, et al.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Logistics in Focus: Orchestrating the Challenges of Cell Therapy

Conversations in Drug Development Trends

These advanced therapeutics harness the power of molecular biology to improve human health. While many market-approved cell therapies available today are autologous products, allogeneic interventions are growing more common.

article thumbnail

Medicinal Chemistry In The Age Of Artificial Intelligence

LifeSciVC

Earlier in my career, graduate-level molecular biology departments arose in universities at a time when those technologies were transformative to the science. That has largely fallen out of favor, and the technologies of molecular biology are today essential technical skills for the cell biologist and geneticist.

article thumbnail

How organoids can redefine pre-clinical research

Drug Target Review

The substantial value of organoids is becoming increasingly recognised by supportive government initiatives developing novel drugs, with a growth rate of 22 percent between 2023 and 2030 and a market size predicted to reach over US $6.5 billion by 2030. This can aid in the development of safer, more effective therapeutic strategies.

article thumbnail

Navigating the challenges of cell therapies

Drug Target Review

He was the Chief Executive Officer and Co-Founder of Invisible Sentinel, a global molecular diagnostics company, where he led the development, manufacturing, and commercial growth of the company’s proprietary diagnostics resulting in a successful sale of the business to bioMerieux, Inc.

Therapies 116
article thumbnail

The essential role of recombinant phage display antibody libraries

Drug Target Review

Methods in Molecular Biology. Journal of Molecular Biology. About the author John Cardone, PhD, Marketing Manager – Custom Antibodies at Bio-Rad Laboratories John Cardone is the Marketing Manager for Bio-Rad’s Custom Antibody Services. 2021;291–306. Prassler J, Thiel S, Pracht C, et al.